KSI-301
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for KSI-301, covering 2024-05-02 to 2024-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) [Phase 3]